Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lot Consistency of Sinovac Quadrivalent Influenza Vaccine in Healthy Subjects
NCT05512494Phase 4Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Nov 2022
- Primary completion
- Jan 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of TetrAnflu in seasonal influenza, sponsored by Sinovac Biotech Ltd.. Started Nov 2022; status: completed.
02
Drugs
TetrAnflu
03
Conditions
seasonal influenza
Beyond the preview
Go deeper on NCT05512494.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05512494.